SEC Form 4 · accession 0001209191-18-049177
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mansoor Raza Mirza
Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | M | 2,236 | $1.485 | A | 2,236 | D | |
| Common Stock | Aug 30, 2018 | M | 264 | $5.643 | A | 264 | D | |
| Common Stock | Aug 30, 2018 | S | 2,500 | $21.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.485 | Aug 30, 2018 | M | 2,236 | D | — | Dec 5, 2022 | Common Stock | 2,236 | 0 | D |
| Stock Option (right to buy)F3 | $5.643 | Aug 30, 2018 | M | 264 | D | — | Sep 30, 2023 | Common Stock | 264 | 10,342 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on December 6, 2013, and the remaining 75% vested in 36 equal monthly installments thereafter.
- F3This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on October 1, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.